Cure Alzheimer's Fund Receives Historic $50 Million Donation for Research Advancement

A Transformative Contribution to Alzheimer's Research

In a landmark event announced on September 26, 2025, the Cure Alzheimer's Fund (CureAlz) has received a staggering $50 million gift from The Cardinal Family Fund. This donation stands as the largest in the organization's 20-year history of funding groundbreaking research aimed at Alzheimer's disease prevention and cure.

The Cardinal Family Fund’s contribution is set to accelerate progress across three key areas crucial for the future of Alzheimer's research:

1. The Cardinal Family Scholars Fund for Alzheimer's Disease Research

This fund is dedicated to empowering the next generation of Alzheimer's researchers. By supporting early and mid-career scientists, the Cardinal Family Scholars Fund aims to nurture talent that will drive innovative research and lead to breakthroughs in understanding and combating Alzheimer's disease.

Funding under this initiative will cover diverse aspects, including personnel, essential lab infrastructure, and professional development opportunities for these emerging leaders in the field.

2. The Cardinal Family Precision Medicine Research Fund

Recognizing the variability in Alzheimer's disease manifestations and risk factors, this fund is focused on advancing precision medicine research. Under the guidance of esteemed scientific leadership, it aims to unravel the complexities surrounding biological factors that contribute to differing Alzheimer's disease risks across various subgroups. The goal is to establish effective prevention strategies and therapeutic solutions tailored to individual needs within the Alzheimer's community.

3. The Cardinal Family Emergency Relief Fund

The instability of federal funding can impede crucial research. This Emergency Relief Fund is established to ensure that core research operations, scientific data, and workforce integrity are sustained even amid funding disruptions. It provides rapid support for maintaining momentum in Alzheimer's research, ensuring that critical efforts continue uninterrupted.

A Message of Gratitude

Henry McCance, Chair and Co-Founder of the Cure Alzheimer's Fund, expressed his deep appreciation for this extraordinary gift, recognizing it as a testament to the Cardinal Family's commitment to collaborative efforts aimed at finding therapeutic solutions and ultimately a cure for Alzheimer's disease.

Meg Smith, the Chief Executive Officer of the organization, echoed these sentiments, highlighting that this significant gift empowers the organization at a critical moment in the Alzheimer's research landscape. Smith articulated her gratitude and emphasized the tremendous responsibility that comes with such support, pledging to uphold the trust placed in them by the Cardinal Family.

About Cure Alzheimer's Fund

Founded in 2004, Cure Alzheimer's Fund is a non-profit organization dedicated to funding innovative research efforts to prevent, slow, or reverse Alzheimer's disease. This organization has made remarkable strides since its inception, having invested over $235 million into research, underpinning its commitment to excellence as shown by a perfect score from Charity Navigator for 13 consecutive years.

Every dollar collected through general donations is directed to research programs, ensuring that all contributions align with the organization's mission to eradicate Alzheimer's disease.

With this recent infusion of funds, the Cure Alzheimer's Fund is poised to drive significant advancements in Alzheimer’s research, making steps towards effective treatments and possibly a cure that can benefit all affected by this challenging disease. As the scientific community rallies to embrace this opportunity, the collaboration and support of the Cardinal Family are set to pave the way for a brighter, Alzheimer-free future.